HSBC Global Research released a report forecasting that escalating tariffs will reduce CSI 300 earnings by 5-7%, vs an earlier estimate of 3-4%. However, the situation remained fluid and could change swiftly. Reflecting recent developments, the broker lowered its targets for the Shanghai Composite Index, CSI 300, and Shenzhen Component Index to 3,600, 4,300, and 11,500, respectively, implying upside of 11.2%, 14.7%, and 16.5%. The broker upgraded healthcare to Overweight and industrials to Neutral, while remaining optimistic on consumer goods and information technology. Related NewsMacquarie Expects Asia to Remain Apple Key Production Base, Bullish on XIAOMI-W & SUNNY OPTICAL for Lower Tariff ImpactDespite current volatility, the broker maintained that China’s stock market will demonstrate long-term resilience, backed by policy measures and broad shift in the China narrative among global investors. The report highlighted a Buy recommendation for select stocks, including XIAOMI-W (01810.HK) -2.350 (-5.452%) Short selling $1.10B; Ratio 15.651% , CHINA RES BEER (00291.HK) -1.250 (-4.545%) Short selling $156.36M; Ratio 23.950% , TINGYI (00322.HK) -0.160 (-1.163%) Short selling $170.16M; Ratio 42.223% , and HANSOH PHARMA (03692.HK) -0.700 (-3.160%) Short selling $94.95M; Ratio 27.979% .(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-04-15 16:25.)